Kang SM - Search Results

1

Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity.

Kim MC, Lee YN, Hwang HS, Lee YT, Ko EJ, Jung YJ, Cho MK, Kim YJ, Lee JS, Ha SH, Kang SM. Kim MC, et al. Among authors: kang sm. Vaccine. 2014 Oct 7;32(44):5824-31. doi: 10.1016/j.vaccine.2014.08.030. Epub 2014 Aug 27. Vaccine. 2014. PMID: 25171841 Free PMC article.

2

Transcutaneous immunization with inactivated influenza virus induces protective immune responses.

Skountzou I, Quan FS, Jacob J, Compans RW, Kang SM. Skountzou I, et al. Among authors: kang sm. Vaccine. 2006 Aug 28;24(35-36):6110-9. doi: 10.1016/j.vaccine.2006.05.014. Epub 2006 May 26. Vaccine. 2006. PMID: 16766095

3

Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.

Quan FS, Compans RW, Cho YK, Kang SM. Quan FS, et al. Among authors: kang sm. Vaccine. 2007 Jan 4;25(2):272-82. doi: 10.1016/j.vaccine.2006.07.041. Epub 2006 Aug 10. Vaccine. 2007. PMID: 16945454

4

Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

Quan FS, Huang C, Compans RW, Kang SM. Quan FS, et al. Among authors: kang sm. J Virol. 2007 Apr;81(7):3514-24. doi: 10.1128/JVI.02052-06. Epub 2007 Jan 24. J Virol. 2007. PMID: 17251294 Free PMC article.

5

Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins.

Quan FS, Sailaja G, Skountzou I, Huang C, Vzorov A, Compans RW, Kang SM. Quan FS, et al. Among authors: kang sm. Vaccine. 2007 May 10;25(19):3841-50. doi: 10.1016/j.vaccine.2007.01.107. Epub 2007 Feb 15. Vaccine. 2007. PMID: 17320250 Free PMC article.

6

Induction of heterosubtypic immunity to influenza virus by intranasal immunization.

Quan FS, Compans RW, Nguyen HH, Kang SM. Quan FS, et al. Among authors: kang sm. J Virol. 2008 Feb;82(3):1350-9. doi: 10.1128/JVI.01615-07. Epub 2007 Nov 21. J Virol. 2008. PMID: 18032492 Free PMC article.

7

A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs.

Quan FS, Steinhauer D, Huang C, Ross TM, Compans RW, Kang SM. Quan FS, et al. Among authors: kang sm. Vaccine. 2008 Jun 19;26(26):3352-61. doi: 10.1016/j.vaccine.2008.03.055. Epub 2008 Apr 11. Vaccine. 2008. PMID: 18468740 Free PMC article.

8

Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination.

Quan FS, Yoo DG, Song JM, Clements JD, Compans RW, Kang SM. Quan FS, et al. Among authors: kang sm. J Virol. 2009 May;83(9):4489-97. doi: 10.1128/JVI.02035-08. Epub 2009 Feb 11. J Virol. 2009. PMID: 19211762 Free PMC article.

9

Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

Kang SM, Yoo DG, Lipatov AS, Song JM, Davis CT, Quan FS, Chen LM, Donis RO, Compans RW. Kang SM, et al. PLoS One. 2009;4(3):e4667. doi: 10.1371/journal.pone.0004667. Epub 2009 Mar 2. PLoS One. 2009. PMID: 19252744 Free PMC article.

10

Influenza vaccines based on virus-like particles.

Kang SM, Song JM, Quan FS, Compans RW. Kang SM, et al. Virus Res. 2009 Aug;143(2):140-6. doi: 10.1016/j.virusres.2009.04.005. Epub 2009 Apr 15. Virus Res. 2009. PMID: 19374929 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,510 results

Search Page

Filters